Medications

FDA approves Dupixent for prurigo nodularis

The U.S. Food and Drug Administration approved Dupixent (dupilumab) as the first treatment for adults with prurigo nodularis, according to Regeneron Pharmaceuticals.

Diseases, Conditions, Syndromes

Four easy ways to reduce your risk of severe COVID-19

Lifestyle choices—such as eating healthy, staying active as well as resting after exercise, and managing stress—may help prevent people from developing severe COVID-19 and mitigate post-infection conditions and symptoms, ...

Health

Four health conditions linked to gum disease

Gum diseases are among the most common chronic human diseases, affecting between 20 to 50% of people worldwide. They happen when plaque, a sticky film of bacteria, builds up on teeth. The earliest stages of gum disease are ...

page 39 from 40